| Measuring beta-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer | |
| Chen, Xiaosong; Wu, Jiayi; Lu, Hongfen; Huang, Ou; Shen, Kunwei | |
| 刊名 | CANCER SCIENCE
 |
| 2012 | |
| 卷号 | 103期号:2 |
| ISSN号 | 1349-7006 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4906843 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Chen, Xiaosong,Wu, Jiayi,Lu, Hongfen,et al. Measuring beta-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer[J]. CANCER SCIENCE,2012,103(2). |
| APA | Chen, Xiaosong,Wu, Jiayi,Lu, Hongfen,Huang, Ou,&Shen, Kunwei.(2012).Measuring beta-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer.CANCER SCIENCE,103(2). |
| MLA | Chen, Xiaosong,et al."Measuring beta-tubulin III, Bcl-2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer".CANCER SCIENCE 103.2(2012). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论